Molbio Diagnostics

Curated news coverage, institutional background, regulatory filings, and investigative reporting across RDU Global.

6 Stories Indexed

Last Updated: Just Now

Verified Entity Intelligence

Macro Economy & Fiscal Policy 07 Oct 2026, 05:37 AM IST

Motilal Oswal Starts Coverage on Molbio Diagnostics With Buy, Sees 21% Upside

Motilal Oswal has initiated coverage on Molbio Diagnostics with a Buy rating and a target price of ₹1,800, implying about 21% upside from current levels. The brokerage argues that the company is well placed to benefit from the shift toward decentralised molecular diagnostics, anchored by its Truenat platform and expanding global footprint.

By RDU Global Wire5 min read

Markets, IPOs & WealthJust now (09:13 AM IST)

Molbio Diagnostics Surges 9% as Jefferies Names It a High-Conviction Top Pick

Molbio Diagnostics shares rallied sharply after Jefferies initiated coverage with a Buy rating and a rare “high-conviction top pick” call, citing substantial upside from current levels. The brokerage set a target price of Rs 1,600, implying about 27% upside from Tuesday’s close and nearly 98% above the company’s Rs 807 IPO price, reinforcing investor interest in the recently listed diagnostics stock.

5 min readRead →

Markets, IPOs & WealthJust now (08:32 AM IST)

Molbio Diagnostics Surges 9% as Jefferies Names Newly Listed Stock a High-Conviction Top Pick

Molbio Diagnostics shares rallied sharply after Jefferies initiated coverage with a Buy rating and a rare high-conviction top-pick call, citing meaningful upside from current levels. The brokerage set a target price of Rs 1,600, implying about 27% upside from Tuesday’s close and nearly 98% above the company’s Rs 807 IPO price.

5 min readRead →

Startups & Venture Capital08 Oct 2026, 11:16 PM IST

Sunfox Technologies Raises $7 Million to Scale Cardiac Diagnostics Platform Spandan

Dehradun-based medtech startup Sunfox Technologies has raised $7 million, or about ₹67 crore, in a Series A round to expand its cardiac diagnostics platform, Spandan. The funding underscores investor appetite for affordable, portable healthcare technologies that can widen access to early heart screening across India and other emerging markets.

5 min readRead →

Startups & Venture Capital08 Oct 2026, 09:47 PM IST

Sunfox Technologies Raises $7 Million to Scale Cardiac Diagnostics Platform Spandan

Dehradun-based medtech startup Sunfox Technologies has secured $7 million in a Series A round to expand its cardiac diagnostics platform, Spandan, as demand rises for faster, more accessible heart screening tools in India. The funding underscores growing investor interest in affordable medical devices that can extend specialist-grade diagnostics beyond major hospitals and into primary care settings.

5 min readRead →

Startups & Venture Capital08 Oct 2026, 10:59 AM IST

Sunfox Technologies Raises $7 Million to Expand Cardiac Diagnostics Platform

Medtech startup Sunfox Technologies has raised $7 million in fresh capital to accelerate the next phase of growth for its cardiac diagnostics platform. The funding will support deeper expansion across India, strengthen global go-to-market capabilities, and fund scale-up and research and development as the company seeks to widen access to early heart screening.

6 min readRead →

🏢 About this Entity

Corporations, startups, regulatory bodies, central banks, ministries and judicial courts. All news mentioning this entity is automatically verified and aggregated into this live intelligence dossier.

Co-Occurring Entities

Entities frequently referenced alongside Molbio Diagnostics:

India(3)Jefferies(2)Tamil cinema(1)Rajinikanth(1)PhysicsWallah(1)Nana Patekar(1)